{"data":[{"accessionNo":"0001172661-26-003483","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":7999025,"percentOfClass":9.74,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0001172661-26-003483","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":7999025,"percentOfClass":9.74,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0001172661-26-003483","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":7999025,"percentOfClass":9.74,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0001897612-26-000611","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001821586","issuerName":"MOONLAKE IMMUNOTHERAPEUTICS","ticker":"MLTX","cusip":"61559X104","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":4280624,"percentOfClass":5.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0001172661-26-003691","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Cormorant Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":3205433,"percentOfClass":4.35,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0001172661-26-003691","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Bihua Chen","reportingCik":null,"personType":"HC,IN","sharesOwned":3205433,"percentOfClass":4.35,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-001697","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-06-25","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":"0001055947","personType":"IA,PN","sharesOwned":16001284,"percentOfClass":19.7,"filedAt":"2026-06-29","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-001697","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-06-25","reportingPerson":"LAMPERT MARK N","reportingCik":"0001233840","personType":"IN","sharesOwned":16001284,"percentOfClass":19.7,"filedAt":"2026-06-29","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-001697","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-06-25","reportingPerson":"BVF INC/IL","reportingCik":"0001056807","personType":"CO","sharesOwned":16001284,"percentOfClass":19.7,"filedAt":"2026-06-29","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-001697","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-06-25","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":"0001803809","personType":"OO","sharesOwned":14902457,"percentOfClass":18.4,"filedAt":"2026-06-29","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-001697","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-06-25","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":"0000918923","personType":"PN","sharesOwned":8302735,"percentOfClass":10.2,"filedAt":"2026-06-29","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-001697","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-06-25","reportingPerson":"BVF I GP LLC","reportingCik":"0001803805","personType":"OO","sharesOwned":8302735,"percentOfClass":10.2,"filedAt":"2026-06-29","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-001697","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-06-25","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":"0001102444","personType":"PN","sharesOwned":6599722,"percentOfClass":8.1,"filedAt":"2026-06-29","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-001697","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-06-25","reportingPerson":"BVF II GP LLC","reportingCik":"0001803806","personType":"OO","sharesOwned":6599722,"percentOfClass":8.1,"filedAt":"2026-06-29","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-001697","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-06-25","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":"0001660683","personType":"PN","sharesOwned":1039238,"percentOfClass":1.3,"filedAt":"2026-06-29","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-001697","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-06-25","reportingPerson":"BVF Partners OS Ltd.","reportingCik":"0001660684","personType":"CO","sharesOwned":1039238,"percentOfClass":1.3,"filedAt":"2026-06-29","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-001697","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-06-25","reportingPerson":"Loy Spike","reportingCik":"0001920549","personType":"IN","sharesOwned":25667,"percentOfClass":0.03,"filedAt":"2026-06-29","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0001172661-26-002221","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Cormorant Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":4480433,"percentOfClass":6.25,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0001172661-26-002221","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Bihua Chen","reportingCik":null,"personType":"HC,IN","sharesOwned":4480433,"percentOfClass":6.25,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-000894","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"BVF INC/IL","reportingCik":"0001056807","personType":"CO","sharesOwned":16001284,"percentOfClass":22.3,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-000894","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"LAMPERT MARK N","reportingCik":"0001233840","personType":"IN","sharesOwned":16001284,"percentOfClass":22.3,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-000894","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":"0001055947","personType":"IA,PN","sharesOwned":16001284,"percentOfClass":22.3,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-000894","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":"0001803809","personType":"OO","sharesOwned":14902457,"percentOfClass":20.8,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-000894","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"BVF I GP LLC","reportingCik":"0001803805","personType":"OO","sharesOwned":8302735,"percentOfClass":11.6,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-000894","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":"0000918923","personType":"PN","sharesOwned":8302735,"percentOfClass":11.6,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-000894","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"BVF II GP LLC","reportingCik":"0001803806","personType":"OO","sharesOwned":6599722,"percentOfClass":9.2,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-000894","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":"0001102444","personType":"PN","sharesOwned":6599722,"percentOfClass":9.2,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-000894","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"BVF Partners OS Ltd.","reportingCik":"0001660684","personType":"CO","sharesOwned":1039238,"percentOfClass":1.4,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-000894","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":"0001660683","personType":"PN","sharesOwned":1039238,"percentOfClass":1.4,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-26-000894","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":"61559X104","securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Loy Spike","reportingCik":"0001920549","personType":"IN","sharesOwned":18985,"percentOfClass":0.03,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0001172661-26-001033","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Cormorant Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":4355433,"percentOfClass":6.1,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0001172661-26-001033","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Bihua Chen","reportingCik":null,"personType":"HC,IN","sharesOwned":4355433,"percentOfClass":6.1,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000902664-25-004943","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A Ordinary Shares, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Behzad Aghazadeh","reportingCik":null,"personType":"HC,IN","sharesOwned":2000000,"percentOfClass":3.15,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000902664-25-004943","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A Ordinary Shares, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Avoro Capital Advisors LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":2000000,"percentOfClass":3.15,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0001172661-25-004733","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2025-11-05","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":4610071,"percentOfClass":6.46,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0001172661-25-004733","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2025-11-05","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":4610071,"percentOfClass":6.46,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0001172661-25-004733","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2025-11-05","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":4610071,"percentOfClass":6.46,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-25-002943","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"BVF INC/IL","reportingCik":"0001056807","personType":"CO","sharesOwned":19751284,"percentOfClass":27.7,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-25-002943","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"LAMPERT MARK N","reportingCik":"0001233840","personType":"IN","sharesOwned":19751284,"percentOfClass":27.7,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-25-002943","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":"0001055947","personType":"IA,PN","sharesOwned":19751284,"percentOfClass":27.7,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-25-002943","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":"0001803809","personType":"OO","sharesOwned":18403927,"percentOfClass":25.8,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-25-002943","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"BVF I GP LLC","reportingCik":"0001803805","personType":"OO","sharesOwned":10235089,"percentOfClass":14.3,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-25-002943","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":"0000918923","personType":"PN","sharesOwned":10235089,"percentOfClass":14.3,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-25-002943","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"BVF II GP LLC","reportingCik":"0001803806","personType":"OO","sharesOwned":8168838,"percentOfClass":11.4,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-25-002943","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":"0001102444","personType":"PN","sharesOwned":8168838,"percentOfClass":11.4,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-25-002943","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":"0001660683","personType":"PN","sharesOwned":1287768,"percentOfClass":1.8,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-25-002943","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"BVF Partners OS Ltd.","reportingCik":"0001660684","personType":"CO","sharesOwned":1287768,"percentOfClass":1.8,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000921895-25-002943","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A ordinary share, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"Loy Spike","reportingCik":"0001920549","personType":"IN","sharesOwned":18985,"percentOfClass":0.03,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000315066-25-002792","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001821586","issuerName":"MOONLAKE IMMUNOTHERAPEUTICS","ticker":"MLTX","cusip":null,"securityClass":"CLASS A COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":726931.33,"percentOfClass":1.1,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000315066-25-002792","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001821586","issuerName":"MOONLAKE IMMUNOTHERAPEUTICS","ticker":"MLTX","cusip":null,"securityClass":"CLASS A COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":726931.33,"percentOfClass":1.1,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"},{"accessionNo":"0000929638-25-003714","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001821586","issuerName":"MoonLake Immunotherapeutics","ticker":"MLTX","cusip":null,"securityClass":"Class A Ordinary Shares","eventDate":"2025-09-30","reportingPerson":"Chen Bihua","reportingCik":null,"personType":"IN,HC","sharesOwned":1994173,"percentOfClass":3.14,"filedAt":"2025-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/mltx"}],"updatedAt":"2026-11-05T15:19:27.066Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/mltx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}